Comparison of treatment outcomes between growth-sparing instrumentation and definitive one-stage fusion for EOS patients ages 6–10 years

Purpose To compare objective outcomes for EOS patients age 6–10 years treated by growth-sparing (GS) surgery or definitive one-stage correction and fusion (DF). Methods We reviewed surgical, radiographic, PFT’s, and EOSQ-24 outcomes for EOS patients > age 6 at index surgery treated at a single institution, minimum 2-year follow-up. Neuromuscular diagnoses were excluded. Results 47 patients underwent index surgery between age 6 and 10.9 years. Twenty-one had DF, 26 had GS surgery (13 MCGR, 13 TGR). Diagnoses included 15 congenital, 15 idiopathic, 17 syndromic. Age at index was 9.1 years DF, 7.8 GS ( p 60 months follow-up, curve magnitudes, spine lengths, PFT’s, or EOSQ scores were equivalent. DF patients had fewer procedures and complications. Conclusion For patients age 6–10.9 years, outcomes were no different at > 5 year follow-up between DF and GS groups. DF patients had fewer total surgeries and complications. Equal outcomes also occurred for tweeners. As a result, GS treatment does not appear to benefit patients > age 8.